Rehovot, Israel

Mati Fridkin


Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2003-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mati Fridkin: Innovator in Neuroprotective Compounds

Introduction

Mati Fridkin is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of neuroprotective compounds, holding a total of 2 patents. His work focuses on developing multifunctional compounds that have the potential to treat various neurological disorders.

Latest Patents

Fridkin's latest patents include innovative formulations aimed at neuroprotection. One of his key inventions is a set of neuroprotective multifunctional compounds and pharmaceutical compositions comprising them. These compounds feature multiple functional moieties, including iron chelation, neuroprotection, and inhibition of various enzymes. They are designed to treat or prevent diseases that can benefit from iron chelation therapy and neuroprotection. Another significant patent involves combination therapy using a pharmaceutical composition that includes a vasoactive intestinal polypeptide (VIP) antagonist alongside a chemotherapeutic agent. This approach aims to enhance the efficacy of cancer treatments.

Career Highlights

Throughout his career, Mati Fridkin has worked with various research institutions, including the Technion Research & Development Foundation Limited. His innovative work has positioned him as a key figure in the development of neuroprotective therapies.

Collaborations

Fridkin has collaborated with esteemed colleagues such as Illana Gozes and Edgar Gelber. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Mati Fridkin's contributions to the field of neuroprotective compounds highlight his innovative spirit and dedication to improving healthcare. His patents reflect a commitment to addressing complex neurological challenges through advanced therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…